Page last updated: 2024-08-24

25-hydroxycholesterol and Degenerative Diseases, Central Nervous System

25-hydroxycholesterol has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Björkhem, I; Deng, HX; Donkervoort, S; Hansson, M; Madrid, RE; Schöls, L; Schüle, R; Siddique, N; Siddique, T; Yang, Y1
Bernard, S; Makoukji, J; Massaad, C; Petit, PX; Schumacher, M; Slomianny, C; Trousson, A1

Other Studies

2 other study(ies) available for 25-hydroxycholesterol and Degenerative Diseases, Central Nervous System

ArticleYear
Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.
    Journal of lipid research, 2010, Volume: 51, Issue:4

    Topics: Adult; Bile Acids and Salts; Cytochrome P450 Family 7; Female; Heterozygote; Homozygote; Humans; Hydroxycholesterols; Male; Middle Aged; Neurodegenerative Diseases; Parents; Phosphorylation; Spastic Paraplegia, Hereditary; Steroid Hydroxylases; tau Proteins

2010
Cross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte death.
    PloS one, 2009, Nov-26, Volume: 4, Issue:11

    Topics: Animals; Apoptosis; Cell Death; Cell Proliferation; Cholesterol; Glucocorticoids; Hydroxycholesterols; Liver X Receptors; Mice; Neurodegenerative Diseases; Oligodendroglia; Orphan Nuclear Receptors; Phospholipases A2; Pregnane X Receptor; Receptors, Steroid; Sterols

2009